UConn Today – Using blood pressure self-monitoring is an effective way to empower patients with hypertension to stick with an exercise program, according to a first-of-its-kind study conducted by a multidisciplinary team of UConn researchers in collaboration with Hartford Hospital.
CCEI
Insurtech Covr sees major hiring, fundraising opportunities downtown
How GM Cruise uses its Dashride acquisition to build a robo-taxi company
Homegrown Hydroponics Project Spreads Around the World
UConn Today – Heiden started the non-profit organization Levo International in his freshman year at UConn to bring hydroponics to those in need in both Haiti and in Connecticut. He soon reached out to Jonathan Moore, an instructor at the operations and information management department (OPIM) in the School of Business.
Hartford InsurTech Hub Holds Demo Day, Completes Second Accelerator Program
Undergraduate non-profit teams up with UConn Child Development lab
Daily Campus – The partnership between Levo International and UConn Child Labs will pilot the non-profit’s first solar-powered hydroponic system, founder of Levo International and a sixth-semester applied and resource economics major with a concentration in international development Christian Heiden, said.
Hartford HealthCare, Trinity, UConn to launch Hartford medtech accelerator
Hartford Business Journal – Hartford HealthCare, Trinity College and the UConn School of Business on Wednesday are expected to announce the launch a medical technology and digital health accelerator, which would join insurance and manufacturing startup programs that have launched in the Capital City in the past few years.
New Technology Designed to Reduce Mortality Rates in Cancer Patients
Why it pays to have Gen Z women on business teams
Fox Business – For most CEOs, HR partners and operations directors who have never given much thought to Gen Z, those born between 1995-2010, data from a new report should be their wake-up call: Pay attention to the “innovation Opens a New Window. generation” if you want to drive growth and global competitiveness.
Torigen Pharmaceuticals Secures $3.1 Million in Series A Financing
Financial Content – Torigen Pharmaceuticals, a company developing personalized cancer immunotherapies for the veterinary market, announced today the completion of a $3.1 million Series A financing round led by Connecticut Innovations, which included the conversion of outstanding convertible debt and interest.